Genital Neoplasms, Female
"Genital Neoplasms, Female" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE).
MeSH Number(s)
C04.588.945.418
C13.351.937.418
Concept/Terms
Genital Neoplasms, Female- Genital Neoplasms, Female
- Neoplasms, Female Genital
- Gynecologic Neoplasms
- Neoplasms, Gynecologic
- Gynecologic Neoplasm
- Neoplasm, Gynecologic
- Female Genital Neoplasms
- Female Genital Neoplasm
- Genital Neoplasm, Female
- Neoplasm, Female Genital
Below are MeSH descriptors whose meaning is more general than "Genital Neoplasms, Female".
Below are MeSH descriptors whose meaning is more specific than "Genital Neoplasms, Female".
This graph shows the total number of publications written about "Genital Neoplasms, Female" by people in Harvard Catalyst Profiles by year, and whether "Genital Neoplasms, Female" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 2 | 2 | 4 |
| 1995 | 3 | 0 | 3 |
| 1997 | 3 | 1 | 4 |
| 1998 | 1 | 0 | 1 |
| 1999 | 3 | 0 | 3 |
| 2000 | 4 | 0 | 4 |
| 2001 | 3 | 0 | 3 |
| 2002 | 5 | 0 | 5 |
| 2003 | 4 | 1 | 5 |
| 2004 | 4 | 0 | 4 |
| 2005 | 7 | 1 | 8 |
| 2006 | 5 | 2 | 7 |
| 2007 | 2 | 3 | 5 |
| 2008 | 5 | 2 | 7 |
| 2009 | 6 | 2 | 8 |
| 2010 | 6 | 0 | 6 |
| 2011 | 3 | 1 | 4 |
| 2012 | 10 | 0 | 10 |
| 2013 | 6 | 0 | 6 |
| 2014 | 8 | 0 | 8 |
| 2015 | 15 | 1 | 16 |
| 2016 | 9 | 2 | 11 |
| 2017 | 12 | 3 | 15 |
| 2018 | 16 | 4 | 20 |
| 2019 | 20 | 3 | 23 |
| 2020 | 11 | 0 | 11 |
| 2021 | 16 | 0 | 16 |
| 2022 | 11 | 0 | 11 |
| 2023 | 20 | 0 | 20 |
| 2024 | 3 | 1 | 4 |
Below are the most recent publications written about "Genital Neoplasms, Female" by people in Profiles.
-
Sialyl-Tn serves as a potential therapeutic target for ovarian cancer. J Ovarian Res. 2024 Apr 02; 17(1):71.
-
Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024 03; 22(2):117-135.
-
Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center. Int J Mol Sci. 2024 Feb 16; 25(4).
-
Systematic Review of the Literature on Multiple Co-occurring Symptoms in Patients Receiving Treatment for Gynecologic Cancers. Semin Oncol Nurs. 2024 Feb; 40(1):151572.
-
Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trials. Gynecol Oncol. 2024 Feb; 181:1-7.
-
How does mobile health engagement technology help gynecologic oncology patients recover from surgery, affect health equity, and impact healthcare costs? Gynecol Oncol. 2023 Nov; 178:A1-A3.
-
The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy. 2023 Nov-Dec; 22(6):716-727.
-
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer. JCO Precis Oncol. 2023 Sep; 7:e2300235.
-
Executive Summary of the Lower Anogenital Tract Cancer Evidence Review Conference. Obstet Gynecol. 2023 09 01; 142(3):708-724.
-
Identification of distinct symptom profiles in patients with gynecologic cancers using a pre-specified symptom cluster. Support Care Cancer. 2023 Jul 22; 31(8):485.